Literature DB >> 12163397

Prostatic intraepithelial neoplasia in genetically engineered mice.

Jae-Hak Park1, Judy E Walls, Jose J Galvez, Minjung Kim, Cory Abate-Shen, Michael M Shen, Robert D Cardiff.   

Abstract

Several mouse models of human prostate cancer were studied to identify and characterize potential precursor lesions containing foci of atypical epithelial cells. These lesions exhibit a sequence of changes suggesting progressive evolution toward malignancy. Based on these observations, a grading system is proposed to classify prostatic intraepithelial neoplasia (PIN) in genetically engineered mice (GEM). Four grades of GEM PIN are proposed based on their architecture, differentiation pattern, and degree of cytological atypia. PIN I lesions have one or two layers of atypical cells. PIN II has two or more layers of atypical cells. PIN III has large, pleomorphic nuclei with prominent nucleoli and the cells tend to involve the entire lumen with expansion of the duct outlines. PIN IV lesions contain atypical cells that fill the lumen and bulge focally into, and frequently compromise, the fibromuscular sheath. Within the same cohorts, the lower grade PINs first appear earlier than the higher grades. Morphometric and immunohistochemical analyses confirm progressive change. Although the malignant potential of PIN IV in mice has not been proven, GEM PIN is similar to human PIN. This PIN classification system is a first step toward a systematic evaluation of the biological potential of these lesions in GEM.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163397      PMCID: PMC1850748          DOI: 10.1016/S0002-9440(10)64228-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  35 in total

Review 1.  Diagnosis of prostatic intraepithelial neoplasia: Prostate Working Group/consensus report.

Authors:  D G Bostwick; R Montironi; I A Sesterhenn
Journal:  Scand J Urol Nephrol Suppl       Date:  2000

Review 2.  Modeling prostate cancer in the mouse.

Authors:  D H Castrillon; R A DePinho
Journal:  Adv Cancer Res       Date:  2001       Impact factor: 6.242

Review 3.  Molecular genetics of prostate cancer.

Authors:  C Abate-Shen; M M Shen
Journal:  Genes Dev       Date:  2000-10-01       Impact factor: 11.361

Review 4.  Mouse models of prostate cancer.

Authors:  P Sharma; N Schreiber-Agus
Journal:  Oncogene       Date:  1999-09-20       Impact factor: 9.867

Review 5.  The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma.

Authors:  J E Green; M A Shibata; K Yoshidome; M L Liu; C Jorcyk; M R Anver; J Wigginton; R Wiltrout; E Shibata; S Kaczmarczyk; W Wang; Z Y Liu; A Calvo; C Couldrey
Journal:  Oncogene       Date:  2000-02-21       Impact factor: 9.867

Review 6.  Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance.

Authors:  R Montironi; R Mazzucchelli; F Algaba; A Lopez-Beltran
Journal:  J Clin Pathol       Date:  2000-09       Impact factor: 3.411

7.  Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis.

Authors:  Minjung J Kim; Robert D Cardiff; Nishita Desai; Whitney A Banach-Petrosky; Ramon Parsons; Michael M Shen; Cory Abate-Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

Review 8.  Use of nude mouse xenograft models in prostate cancer research.

Authors:  W M van Weerden; J C Romijn
Journal:  Prostate       Date:  2000-06-01       Impact factor: 4.104

9.  Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth.

Authors:  N Schreiber-Agus; Y Meng; T Hoang; H Hou; K Chen; R Greenberg; C Cordon-Cardo; H W Lee; R A DePinho
Journal:  Nature       Date:  1998-06-04       Impact factor: 49.962

10.  Pten is essential for embryonic development and tumour suppression.

Authors:  A Di Cristofano; B Pesce; C Cordon-Cardo; P P Pandolfi
Journal:  Nat Genet       Date:  1998-08       Impact factor: 38.330

View more
  86 in total

Review 1.  Krüppel cripples prostate cancer: KLF6 progress and prospects.

Authors:  Goutham Narla; Scott L Friedman; John A Martignetti
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

2.  eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression.

Authors:  Luc Furic; Liwei Rong; Ola Larsson; Ismaël Hervé Koumakpayi; Kaori Yoshida; Andrea Brueschke; Emmanuel Petroulakis; Nathaniel Robichaud; Michael Pollak; Louis A Gaboury; Pier Paolo Pandolfi; Fred Saad; Nahum Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

Review 3.  Mouse models of prostate cancer: picking the best model for the question.

Authors:  Magdalena M Grabowska; David J DeGraff; Xiuping Yu; Ren Jie Jin; Zhenbang Chen; Alexander D Borowsky; Robert J Matusik
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

4.  Differentiation of the ductal epithelium and smooth muscle in the prostate gland are regulated by the Notch/PTEN-dependent mechanism.

Authors:  Xinyu Wu; Kun Xu; Lixia Zhang; Yan Deng; Peng Lee; Ellen Shapiro; Marie Monaco; Helen P Makarenkova; Juan Li; Herbert Lepor; Irina Grishina
Journal:  Dev Biol       Date:  2011-05-20       Impact factor: 3.582

5.  TR4 nuclear receptor functions as a tumor suppressor for prostate tumorigenesis via modulation of DNA damage/repair system.

Authors:  Shin-Jen Lin; Soo Ok Lee; Yi-Fen Lee; Hiroshi Miyamoto; Dong-Rong Yang; Gonghui Li; Chawnshang Chang
Journal:  Carcinogenesis       Date:  2014-02-28       Impact factor: 4.944

6.  Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity.

Authors:  Darren J Baker; Fang Jin; Karthik B Jeganathan; Jan M van Deursen
Journal:  Cancer Cell       Date:  2009-12-08       Impact factor: 31.743

7.  Dietary resveratrol prevents development of high-grade prostatic intraepithelial neoplastic lesions: involvement of SIRT1/S6K axis.

Authors:  Guiming Li; Paul Rivas; Roble Bedolla; Dinesh Thapa; Robert L Reddick; Rita Ghosh; Addanki P Kumar
Journal:  Cancer Prev Res (Phila)       Date:  2012-12-17

8.  Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee.

Authors:  Michael Ittmann; Jiaoti Huang; Enrico Radaelli; Philip Martin; Sabina Signoretti; Ruth Sullivan; Brian W Simons; Jerrold M Ward; Brian D Robinson; Gerald C Chu; Massimo Loda; George Thomas; Alexander Borowsky; Robert D Cardiff
Journal:  Cancer Res       Date:  2013-04-22       Impact factor: 12.701

9.  Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer.

Authors:  Teresa Chiaverotti; Suzana S Couto; Annemarie Donjacour; Jian-Hua Mao; Hiroki Nagase; Robert D Cardiff; Gerald R Cunha; Allan Balmain
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

10.  Disruption of PPARgamma signaling results in mouse prostatic intraepithelial neoplasia involving active autophagy.

Authors:  M Jiang; S Fernandez; W G Jerome; Y He; X Yu; H Cai; B Boone; Y Yi; M A Magnuson; P Roy-Burman; R J Matusik; S B Shappell; S W Hayward
Journal:  Cell Death Differ       Date:  2009-10-16       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.